Annotated Medicine and Device Lists


Intermediate-acting insulin

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 18.5.1. Insulins No observations
PAHO Strategic Fund Medicine List 8.2. Insulins and other antidiabetic agents Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 18.5 Insulins and Other Anti-Diabetics No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 39. Hipoglucemiantes e hiperglucemiantes No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 18.5.1. Insulins No observations
PAHO Strategic Fund Medicine List 8.2. Insulins and other antidiabetic agents Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Haiti. National List of Essential Medicines 18.04 Antidiabetics and other drugs used in diabetes No observations

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 8.2. Insulins and other antidiabetic agents Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.

This medicine is present in:

List Section Observation
Barbados. Barbados National Drug Formulary (BNDF) 68.20.08 Insulins No observations

Information Resources: Intermediate-acting insulin

Loading ...
Loading ...
Loading ...
No information available